Phuturdex › Diseases › Hemorrhage
Drugs in development · updated 30 October 2026
Hemorrhage: drugs in development
As of 30 October 2026 there are 36 active clinical trials (recruiting or ongoing, phases I–III) on 25 drugs for hemorrhage. 7 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| CenvacibartREGN7508 | III | 4 | NCT07626411 |
| Mezagitamab | III | 2 | NCT06948318 |
| REGN9933 | II | 2 | NCT07175428 |
| BT200 | II | 1 | NCT07273721 |
| CAY001 | I | 1 | NCT06845839 |
| REGN9533 | I | 1 | NCT07759167 |
| Carbetocin | Early I | 1 | NCT07721623 |
Sorted by most advanced phase and number of active trials.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| Tranexamic AcidTransexamic acid, Lysteda® | III | 10 | NCT07672158 |
| ApixabanEliquis, Abanta® | III | 4 | NCT07626411 |
| AspirinVazalore®, Durlaza® | III | 4 | NCT07524335 |
| WarfarinPanwarfin®, Athrombin-K® | III | 3 | NCT03636295 |
| HeparinUnfractionated heparin, Heparin Sodium Preservative Free® | II–III | 2 | NCT04273607 |
| BupivacaineExparel, Bupivacain | II–III | 1 | NCT06456255 |
| DesmopressinDDAVP, Desmopresin | III | 1 | NCT06337838 |
| EnoxaparinLovenox, Lovenox (Preservative Free)® | II–III | 1 | NCT04924322 |
| EpinephrineAdrenaline, Adrenalin® | II–III | 1 | NCT06456255 |
| MarstacimabPF-06741086, Hympavzi® | III | 1 | NCT05611801 |
| RivaroxabanRivoroxaban, Yulzety® | III | 1 | NCT07456085 |
| TachoSil | III | 1 | NCT06664775 |
| TicagrelorBrilinta®, Brilique® | III | 1 | NCT07257198 |
| FEIBA | II | 1 | NCT07032792 |
| Oxytocin nasal sprayOxytocin 10 Usp Units In Dextrose 5%®, Oxytocin 5 Usp Units In Dextrose 5%® | II | 1 | NCT06141447 |
Sorted by most advanced phase and number of active trials. Showing 15 of 18 drugs.
All 25 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Autoimmune thrombocytopenic purpura 53 drugs
- Cerebral hemorrhage 23 drugs
- Subarachnoid hemorrhage 14 drugs
- Postpartum hemorrhage 4 drugs
- Stroke 70 drugs
- Ischemic stroke 94 drugs
- Surgical blood loss 8 drugs
- Chronic subdural hematoma 4 drugs
- Intracranial Hemorrhages 5 drugs
- Epistaxis 6 drugs
- Gastrointestinal Hemorrhage 6 drugs
- Headache 12 drugs
Broader categories
- Cardiovascular disease 71 drugs
- Vascular disease 16 drugs
- Brain Diseases 23 drugs
- Central nervous system disease 38 drugs
- Nervous System Diseases 39 drugs
- Heart disease 17 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: NLM MeSH; NLM MeSH term: D006470 “Hemorrhage”.